Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPJURCZAK, W.MOREIRA, I.GOVINDBABU, K. SettyMUNHOZ, E.ECHEVESTE, M-A.GIRI, P.CASTRO, N.PEREIRA, J.LUIZA, A.ALEXEEV, S.OSMANOV, D.ZHU, P.ALEXANDROVA, S.ZUBEL, A.HARLIN, O.AMERSDORFFER, J.2018-02-222018-02-222017ANNALS OF ONCOLOGY, v.28, suppl.5, 20170923-7534https://observatorio.fm.usp.br/handle/OPI/25089engrestrictedAccessEquivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III studyconferenceObjectCopyright OXFORD UNIV PRESSOncology1569-8041